Phase 2 study of intermittent pulse dacomitinib in patients with advanced non-small cell lung cancers Article

Industry Collaboration International Collaboration

cited authors

  • Yu, Helena A.; Ahn, Myung-Ju; Cho, Byoung Chul; Gerber, David E.; Natale, Ronald B.; Socinski, Mark A.; Giri, Nagdeep; Quinn, Susan; Sbar, Eric; Zhang, Hui; Giaccone, Giuseppe

authors

Publication Date

  • October 1, 2017

webpage

published in

category

keywords

  • Dacomitinib
  • Egfr
  • Non-small-cell lung cancer
  • Pulsatile dosing
  • T790M
  • Tyrosine kinase inhibitors

start page

  • 195

end page

  • 199

volume

  • 112